Heres how these two medications really compare
BPC-157 is also the stronger choice for research involving drug-induced damage or neuroprotection
Regular follow-up with your GP or specialist diabetes team should include: HbA1c monitoring (typically every 3-6 months initially, then 6-12 monthly when stable) [9] [26] Weight and cardiovascular risk factor tracking Medication adjustment as needed Early identification of complications Psychological support for behaviour change When to seek medical advice : Contact your GP if you experience unexplained weight regain, worsening diabetes symptoms (increased thirst, urination, fatigue), or wish to discuss treatment modifications
It combines a Growth Hormone Releasing Hormone (GHRH) analog with a Growth Hormone Secretagogue (GHS), creating a much more potent and physiologically natural response than either compound could on its own
Indeed, a previous report shows that cellular stress can promote non cells in the islet to exhibit celllike properties (54)
As a result, GHRP-2 also appears to stimulate the production of growth hormone (GH) in pituitary cells that express this receptor